None listed
Conditions
Interventions
Medical Device : All patients enrolled this trial will have midline incision for the extraction of resected specimen.
For the closure of midline incision, patients allocated in experimental group will
Sponsors
Jeonbuk National University Hospital
Eligibility
Sex/Gender
All
Inclusion criteria
Inclusion criteria: ? at least 20 years old ? patient who understand the aim of this trial and take a signature on the informed consent form ? pathologically confirmed as colorectal or gastirc cancers ? pathological type as adenocarcinoma, mucinous carcinoma, signet ring cell carcinoma
Exclusion criteria
Exclusion criteria: ? open surgery ? midline incision length shorter than 1 cm ? midline incision length longer than 10 cm ? previous operation history and presence of scar ? other site incision rather than midline incision ? emergency surgery, for example patients with obstruction or perforation ? palliative surgery ? patients who need stoma ? Bypass surgery ? patients who have peritoneal seedings ? patients who have intractable wound, fracture, peptic ulcer, intraperitoneal abscess ? patients who have incisional hernia caused by previous surgery or who have received incisional herniorraphy with mesh ? patients who enrolled other clinical trial within 6months, or patients who have received medicines for any clinical trial ? patients who do not want to be enrolled in this trial ? if investigators make a decision that patients are unacceptable or impossible to participate this trial
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| incisional hernia incidence rate | — |
Secondary
| Measure | Time frame |
|---|---|
| Herniorrhaphy for the treatment of incisional hernia;surgical site infection rate;Patient-reported outcomes | — |
Countries
Korea, Republic of
Contacts
Public ContactYoun Ja Lee
Jeonbuk National University Hospital
Outcome results
None listed